Offer new treatments only as part of post-market trials until data on meaningful outcomes are available, says Ben Goldacre to BMJ

Watch the video from the BMJ channel below:

Share:

No comments:

Post a Comment

Featured post

How to Compare Identity Theft Protection Products

When it comes to shielding your identification, perhaps the most vital issue to don't forget is without a doubt getting started out. Mo...